Brief Tailored Smoking Cessation Counseling in a Lung Cancer Screening Population is Feasible: A Pilot Randomized Controlled Trial

被引:29
|
作者
Marshall, Henry M. [1 ]
Courtney, Deborah A. [1 ]
Passmore, Linda H. [1 ]
McCaul, Elizabeth M. [1 ]
Yang, Ian A. [1 ]
Bowman, Rayleen V. [1 ]
Fong, Kwun M. [1 ]
机构
[1] Univ Queensland, Thorac Res Ctr, Prince Charles Hosp, Rode Rd, Brisbane, Qld 4032, Australia
基金
英国医学研究理事会;
关键词
PRIMARY-CARE PROVIDERS; COMPUTED-TOMOGRAPHY; INTERVENTION; ATTITUDES; PARTICIPANTS; PERCEPTIONS; DEPENDENCE; BELIEFS;
D O I
10.1093/ntr/ntw010
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Maximizing smoking abstinence in lung cancer screening participants is important to reduce individual risk of disease and improve screening cost-effectiveness; however, the optimal strategy remains undefined. We hypothesized that a single session of tailored face-to-face counseling on the day of screening CT scan, coupled with audio and printed cessation information would be feasible to deliver in a CT screening trial. Methods: We randomized volunteer smokers in the Queensland Lung Cancer Screening Study to intervention (counseling session, audio quit materials, printed quit materials, Quitline contact details) or control group (printed quit materials, Quitline contact details). Participants self-reported point prevalence quit rates at 1 year. Results: Fifty-five smokers were enrolled; 28 randomized to intervention and 27 controls. Median cigarette consumption was 25/day; 54/55 smoked at least 15 cigarettes per day. Median smoking duration was 46 years. Median Fagerstrom dependence score was 6. In total 58% did not report any quit attempt in the prior 12 months. Mean duration of counseling was 26.5 minutes. After 1 year, four participants (14.3%) in the intervention group and five participants (18.5%) in the control group had quit (P = .74). Combined annual point prevalence quit rate was 16.4%. Conclusions: Although feasible to deliver a single session of tailored counseling on the day of screening this intervention had no discernible impact on cessation over and above printed materials and Quitline access. As participants exhibited hardcore smoking characteristics, more intensive strategies, in larger cohorts, should be explored. Implications: The optimal smoking cessation strategy within a lung cancer screening program is not known. This study demonstrates that a single session of counseling can be feasibly delivered on the day of screening but may not have been intensive enough for long-term, hard-core smokers.
引用
收藏
页码:1665 / 1669
页数:5
相关论文
共 50 条
  • [31] A combined smoking cessation intervention within a lung cancer screening trial: a pilot observational study
    Pozzi, Paolo
    Munarini, Elena
    Bravi, Francesca
    Rossi, Marta
    La Vecchia, Carlo
    Boffi, Roberto
    Pastorino, Ugo
    TUMORI JOURNAL, 2015, 101 (03): : 306 - 311
  • [32] Computer-tailored smoking cessation intervention in a general population setting in Germany: Outcome of a randomized controlled trial
    Schumann, Anja
    John, Ulrich
    Baumeister, Sebastian E.
    Ulbricht, Sabina
    Rumpf, Hans-Juergen
    Meyer, Christian
    NICOTINE & TOBACCO RESEARCH, 2008, 10 (02) : 371 - 379
  • [33] A brief alcohol intervention during smoking cessation treatment in daily cigarette smokers: A pilot randomized controlled trial
    Cheung, Yee Tak Derek
    Mak, Tin Shun Titan
    Luk, Tzu Tsun
    Ching, Kam-wing Joe
    Wong, Nga-ting Grace
    Chan, Ching Han Helen
    Wang, Man Ping
    Lam, Tai Hing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] A PILOT RANDOMIZED CONTROLLED TRIAL OF SMOKING CESSATION INDUCTION TREATMENT FOR RURAL, UNDERSERVED CANCER SURVIVORS
    Burris, Jessica
    Bowling, William
    ANNALS OF BEHAVIORAL MEDICINE, 2023, 57 : S274 - S274
  • [35] Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial
    Pastorino, Ugo
    Ladisa, Vito
    Trussardo, Sara
    Sabia, Federica
    Rolli, Luigi
    Valsecchi, Camilla
    Ledda, Roberta E.
    Milanese, Gianluca
    Suatoni, Paola
    Boeri, Mattia
    Sozzi, Gabriella
    Marchiano, Alfonso
    Munarini, Elena
    Boffi, Roberto
    Gallus, Silvano
    Apolone, Giovanni
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (11) : 1276 - 1286
  • [36] A pilot randomized controlled trial of a tailored smoking cessation program for people living with HIV in the Washington, DC metropolitan area
    Kierstead, Elexis C.
    Harvey, Emily
    Sanchez, Denisse
    Horn, Kimberly
    Abroms, Lorien C.
    Spielberg, Freya
    Stanton, Cassandra A.
    Debnam, Charles
    Cohn, Amy M.
    Gray, Tiffany
    Magnus, Manya
    Patel, Minal
    Niaura, Raymond
    Elf, Jessica L.
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [37] A pilot pragmatic randomized controlled trial of a nicotine metabolite ratio-guided smoking cessation intervention in a lung health and screening program
    Siegel, Scott D.
    Budziszewski, Ross
    Layton, Essie
    Nam, Brian
    Schnoll, Robert
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2024, 12
  • [38] A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting
    Williams, R.
    Cao, P.
    Li, T.
    Luta, G.
    Smith, L.
    Mandelblatt, J.
    Jeon, J.
    Zhao, A.
    Levy, D.
    Davis, K.
    Stanton, C.
    Niaura, R.
    Abrams, D.
    Lobo, T.
    Anderson, E.
    Meza, R.
    Jayasekera, J.
    Taylor, K. L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S28 - S28
  • [39] A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting
    Taylor, Kathryn L.
    Williams, Randi M.
    Li, Tengfei
    Luta, George
    Smith, Laney
    Davis, Kimberly M.
    Stanton, Cassandra
    Niaura, Raymond
    Abrams, David
    Lobo, Tania
    Mandelblatt, Jeanne
    Jayasekera, Jinani
    Meza, Rafael
    Jeon, Jihyoun
    Cao, Pianpian
    Anderson, Eric D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (10): : 1410 - 1419
  • [40] The Results of Mandatory Smoking Cessation Intervention in a Population-Based Lung Cancer Screening Trial
    Lee, E.
    Kim, Y.
    Lee, J.
    Lim, J.
    Kim, H. Y.
    Goo, J. M.
    Lee, C. T.
    Jang, S. H.
    Lee, W. C.
    Sung, S. W.
    Lee, C. W.
    Choi, K. S.
    Park, B.
    Lee, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S522 - S523